Navigation Links
Dr. Yamo Deniz to Join Cytos Biotechnology's Board of Directors
Date:12/3/2013

otential new treatment for asthma.

CYT003 has a novel mechanism of action that inhibits the immune response that causes asthma, and may therefore be beneficial for the control of asthma. In a successfully completed Phase 2a study, CYT003 was shown to maintain asthma control and lung function in patients with persistent allergic asthma, despite withdrawal of standard therapy with inhaled corticosteroids. CYT003 has been shown to have a good safety and tolerability profile in more than 450 individuals receiving the active agent so far.

Cytos was founded in 1995 as a spinoff from the Swiss Federal Institute of Technology (ETH) in Zurich. It is located in Schlieren (Zurich), Switzerland. The Company is listed according to the Main Standard on the SIX Swiss Exchange Ltd under the symbol CYTN.

http://www.cytos.com 

Forward Looking Statements

This media release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements.  You are urged to consider statements that include the words "committed", "could", "will", "plans", "enable", "expected", "proposed", "intends", "planned," or the negative of those words or other similar words to be uncertain and forward-looking. Factors that may cause actual results to differ materially from any future results expressed or implied by any forward-looking statements include scientific, business, economic and financial factors, including that CYT003 may not demonstrate safety or efficacy in clinical trials, that there
'/>"/>

SOURCE Cytos Biotechnology Ltd
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Extraordinary Shareholders Meeting of Cytos Biotechnology Ltd: Shareholders Approve All Resolutions
2. Cytos Biotechnology Ltd Reports Third Quarter 2013 Financial Results and Recent Developments
3. Cytos Biotechnology Ltd Reports First Quarter 2013 Financial Results and Recent Development
4. The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study Results With Cytos Biotechnologys CYT003 for the Treatment of Allergic Asthma
5. Cytos Biotechnology Strengthens Management Team
6. Enteris BioPharma Forms Scientific Advisory Board to Enhance Leadership in Oral Delivery of Peptide and Small Molecule Drugs
7. Intarcia Therapeutics Appoints Nancy Thornberry to Board of Directors
8. Scioderm Appoints Orphan Product Executives to Board of Directors
9. ImaginAb Expands Scientific Advisory Board
10. CMDBioscience Appoints Tomi Sawyer to Scientific Advisory Board; Entrepreneurial Drug Hunter and Distinguished Scholar Named as Founding Chair
11. Business Guru Michael E. Gerber appointed to ReliantHeart Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ALTO, Calif. , July 1, 2015 /PRNewswire/ ... focused on the development of groundbreaking drugs to ... (ALS), announced today that Robert G. Miller ... Center at Sutter Health,s California Pacific Medical Center ... The ALS Association for $1.5 million to help ...
(Date:7/1/2015)... ... ... A newly launched business plan contest will ask startup companies from around ... sciences R&D. The Pistoia Alliance President’s Startup Challenge 2015 will see small and medium ... expert mentorship from a senior industry figure drawn from the Pistoia Alliance membership. , ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... combat pathogen transmission. CTI’ new Medical Joysticks have an impermeable molecular barrier ... have an operator control device that will increase healthcare worker safety and reduce ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... take part in the first half of “Integrative Biotechnology,” an applied biotechnology course ... in summer 2014, this course combines students from both universities and is taught ...
Breaking Biology Technology:Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3Sanitized Medical Joysticks for a Safer and Healthier Work Environment 2Rivier University and Beijing City University Academic and Cultural Exchanges Begin 2
... Microchip Biotechnologies,Inc. (MBI) announces that it ... GE Healthcare that significantly enhances MBI,s intellectual,property ... The,patents cover design and methods for creating ... patents continues to build our strong,intellectual property ...
... were met ... TSX Exchange Symbol: RVX, ... (TSX:RVX) announced today that it has,completed dosing of its Phase ... RVX-208, which addresses the,dyslipidemia market. "Initial results from the emerging ...
... the Diagnosis of Uncertain ... ... Diagnostics, Inc.,a genomics-based diagnostics company focused on oncology, today announced,the launch ... Laboratory. The new test aids in the diagnosis of,tumors of uncertain ...
Cached Biology Technology:Microchip Biotechnologies, Inc. Enters Into License Arrangement With GE Healthcare for Fundamental Microfluidic Patents 2Dosing for RVX-208 Phase 1a Clinical Study Completed 2Pathwork(R) Diagnostics Launches Genomics-Based Test For Hard-To-Identify Tumors Through Its CLIA-Certified Laboratory 2Pathwork(R) Diagnostics Launches Genomics-Based Test For Hard-To-Identify Tumors Through Its CLIA-Certified Laboratory 3
(Date:6/30/2015)... 2015 To bolster its efforts and commitment to ... today the addition of two new team members. ... and David Raviv will act as head of ... commitment to providing the most secure solutions for the enterprise ... Layer 7 Technologies, a provider of security and management products, ...
(Date:6/25/2015)...  Imagine a tool specifically designed to help you ... That,s exactly what USANA,s True Health Assessment ... health program provides a personalized approached to measuring your ... lifestyle and nutrition. At the Canadian ... USANA,s THA was honored with the Industry Innovation Award. ...
(Date:6/24/2015)... DUBLIN , June 22, 2015 ... has announced the addition of the "Huawei ... Analysis" report to their offering. ... going to the opposite direction than Apple,s and ... innovative fingerprint sensor developed by Fingerprint Cards, a ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2
... field trials of Miscanthus x giganteus , a towering ... yields, though reduced somewhat after five years of growth, are ... ), another perennial grass used as a bioenergy feedstock. ... yields found in earlier studies of the crop in Europe, ...
... Sciences (AIBS) has selected three individuals as winners of ... This is the third year AIBS has sponsored ... members of the scientific community to showcase for the ... informing natural resources management, addressing climate change, improving human ...
... For some 5,000 years, cultivated silkworms have been spinning ... finest clothing. But current dyeing practices produce wastewater that ... a new, "greener" dyeing method in which they coax ... leaves. Their findings are published in the journal ...
Cached Biology News:The first decade: Team reports on US trials of bioenergy grasses 2The first decade: Team reports on US trials of bioenergy grasses 3AIBS announces winners of Faces of Biology photo competition 2
... G Dye runs faster than Bromophenol ... agarose gels.,Orange G dye migrates with ... The migration at this size,prevents the ... indicates the front of DNA migration.,The ...
... Description: 100 ... Detects 70 kDa YAP from Human/mouse/rat ... immunohistochemistry. Research ... Storage: -20C ...
Rabbit polyclonal to QKI...
Mouse polyclonal antibody to QPRT - quinolinate phosphoribosyltransferase (nicotinate-nucleotide pyrophosphorylase (carboxylating))...
Biology Products: